Kawasaki disease resistant to immunoglobulin G therapy

Annals of Tropical Paediatrics

Volumn 23, Issue 3, 2003, Pages 187-191

  Venugopalan, P ^a   Jaya, S ^a   Al Azri, M A H ^a   Piopongco, E ^a  

^a SULTAN QABOOS UNIVERSITY HOSPITAL   (Oman)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CORTICOSTEROID; IMMUNOGLOBULIN G; INOTROPIC AGENT; PREDNISOLONE; STEROID;

CHILD HEALTH; DISEASE PREVALENCE;

ARTICLE; CARDIOMEGALY; CASE REPORT; CONJUNCTIVA DISEASE; CORONARY ARTERY ANEURYSM; CORTICOSTEROID THERAPY; DIAGNOSTIC TEST; DOPPLER ECHOGRAPHY; DRUG MEGADOSE; ECHOCARDIOGRAPHY; FEVER; FOLLOW UP; HEART FAILURE; HUMAN; IRRITABILITY; LABORATORY TEST; LYMPHADENOPATHY; MALE; MOUTH DISEASE; MUCOCUTANEOUS LYMPH NODE SYNDROME; MYOCARDITIS; PRESCHOOL CHILD; RASH; REMISSION; TREATMENT OUTCOME; TREATMENT PLANNING; VASCULITIS;

ADRENAL CORTEX HORMONES; CHILD, PRESCHOOL; CORONARY ANEURYSM; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOGLOBULIN G; IMMUNOTHERAPY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; MYOCARDITIS; TREATMENT OUTCOME;

EID: 0141737502     PISSN: 02724936     EISSN: None     Source Type: Journal    
DOI: 10.1179/027249303322296501     Document Type: Article

References (11)

1. Brogan PA, Bose A, Burgner D, et al. Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future research. Arch Dis Child 2002; 86:286-90.
2. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Clinical observation of 50 patients. Jpn J Allergy 1967; 16:178-222.
3. Gardner-Medwin JM, Dolezalova P, Cummins C, Southwood TR. Incidence of Henoch-Schonlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet 2002; 360:1197-202.
4. Tizard JE. Recognition and management of Kawasaki disease. Curr Paediatr 1999; 8:97-101.
5. Burns JC, Shike H, Gordon JB, et al. Sequelae of Kawasaki disease in adolescents and young adults. J Am Coll Cardiol 1996; 28:253-7.
6. De Zori A, Clan SD, Gauvreau K, et al. Coronary artery dimensions may be misclassified as normal in Kawasaki disease. J Pediatr 1998; 133:254-8.
7. Durongpisitkul K, Gururaj VJ, Park JM, Martin CF. The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobin treatment. Pediatrics 1995; 96:1057-61.
8. Han RK, Silverman ED, Newman A, McCrindle BW. Management and outcome of persistent or recurrent fever after initial intravenous gamma globulin therapy in acute Kawasaki disease. Arch Pediatr Adolesc Med 2000; 154:694-9.
9. Kato H, Koike S, Yokayama T. Kawasaki disease: effect of treatment on coronary artery involvement. Pediatrics 1979; 63:175-9.
10. Wright DA, Newburger JW, Baker A, Sundel RP. Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids. J Pediatr 1996; 128:146-9.
11. Dale RC, Saleem MA, Daw S, Dillon MJ. Treatment of severe complicated Kawasaki disease with oral prednisolone and aspirin. J Pediatr 2000; 137:723-6.